The ASX has slipped on Tuesday. Oil kept climbing and miners dragged, while software stocks finally got some love.
The FDA has cleared Curvebeam’s module for measuring bone mineral density – a key development in the company’s commercial rollout.
The dose optimisation committee could influence the next stage of development of PTX-100 as the company reaches halfway dosing milestone.
Gina Rinehart’s Hancock Prospecting plans to invest $8.7 million in a private placement, bringing its stake in the company to 13.5%.
Tylah Tully looks at the new plans for drilling a kilometre deep into an emerging rare earth system at Tundulu.
